What is the next step in managing a patient with uncontrolled hypertension despite being on lisinopril 20 mg, hydrochlorothiazide 25 mg, and amlodipine 10 mg?

Add Spironolactone 25-50 mg Daily as Your Fourth Agent

In a patient with uncontrolled hypertension on lisinopril 20mg, HCTZ 25mg, and amlodipine 10mg, you should add spironolactone 25-50 mg daily as the fourth-line agent, provided the eGFR is ≥45 mL/min/1.73 m² and potassium is monitored closely. 1

Step 1: Confirm True Resistant Hypertension

Before adding a fourth agent, you must exclude pseudoresistance:

• Verify accurate BP measurement technique - Ensure proper cuff size, patient positioning, and measurement protocol
• Obtain out-of-office BP readings - Use home BP monitoring or 24-hour ambulatory monitoring to exclude white-coat hypertension 1
• Assess medication adherence - Non-adherence is present in 29-50% of apparent resistant hypertension cases 2
• Review interfering medications - NSAIDs, decongestants, oral contraceptives, and other agents can elevate BP or reduce antihypertensive efficacy 1

Step 2: Optimize Current Regimen FIRST

Critical: Replace HCTZ with chlorthalidone or indapamide before adding a fourth drug. Thiazide-like diuretics (chlorthalidone, indapamide) provide superior BP reduction of 6-8 mmHg compared to HCTZ and offer better cardiovascular protection 1. This single change may achieve BP control without additional agents.

Your current regimen already includes:

• ACE inhibitor (lisinopril 20mg) - at maximum dose
• Calcium channel blocker (amlodipine 10mg) - at maximum dose
• Thiazide diuretic (HCTZ 25mg) - suboptimal choice

Step 3: Screen for Secondary Hypertension

Secondary causes are more common in resistant hypertension. Evaluate for:

• Primary aldosteronism - Most common secondary cause; check aldosterone-to-renin ratio
• Obstructive sleep apnea - Particularly in obese patients
• Renal artery stenosis - Especially if abrupt onset or worsening renal function
• Chronic kidney disease - Check eGFR and urine albumin 1

Step 4: Add Spironolactone as Fourth Agent

Spironolactone 25-50 mg daily is the evidence-based fourth-line agent with Class 1, Level B-R recommendation 1:

• Reduces 24-hour systolic BP by 6.6-8.7 mmHg compared to placebo 1
• Superior to doxazosin and bisoprolol in head-to-head trials 1
• More effective than clonidine for 24-hour BP reduction 1

Prerequisites for Spironolactone:

• eGFR ≥45 mL/min/1.73 m² (contraindicated below this threshold) 1
• Baseline potassium <5.0 mEq/L
• Monitor potassium within 1-2 weeks after initiation 3

Common Pitfalls:

• Hyperkalemia occurs in 4-40% of patients - More common with lower eGFR, diabetes, or concurrent NSAIDs 1
• Antiandrogenic effects - Gynecomastia, breast tenderness, erectile dysfunction may limit tolerability 1

Alternative Fourth-Line Agents (If Spironolactone Not Tolerated)

If spironolactone causes hyperkalemia or antiandrogenic side effects:

1. Amiloride 10-20 mg - Equally effective as spironolactone without antiandrogenic effects 1
2. Eplerenone 25-100 mg - More selective MRA, but RCTs show inconsistent BP reduction at standard doses; may require higher dosing 1
3. Beta-blockers (bisoprolol) - Third-line option per ESC guidelines 4
4. Alpha-blockers (doxazosin) - Less effective than spironolactone 1

Additional Considerations

If eGFR <40 mL/min/1.73 m²:

Switch from thiazide-like diuretic to loop diuretic (furosemide) twice daily, as thiazide efficacy diminishes significantly below this threshold 5

Lifestyle Reinforcement:

• Sodium restriction to <2g/day - Critical in resistant hypertension 4
• Weight loss if BMI >25
• Limit alcohol consumption
• Regular aerobic exercise

Device-Based Therapy:

Renal denervation may be considered in highly selected patients with suitable anatomy (renal artery diameter 3-8 mm, eGFR ≥40 mL/min/1.73 m²) who remain uncontrolled despite optimal medical therapy, but only after shared decision-making and at experienced centers 1, 4

Key Monitoring Parameters

After adding spironolactone:

• Serum potassium and creatinine at 1-2 weeks, then monthly for 3 months
• BP reassessment at 4 weeks - If still uncontrolled, increase spironolactone to 50 mg if tolerated
• Watch for drug interactions - Lisinopril + spironolactone significantly increases hyperkalemia risk 3

The 2025 ACC/AHA guidelines provide the strongest evidence that spironolactone addition to your patient's current regimen (after optimizing the diuretic component) represents the most effective strategy for achieving BP control while minimizing cardiovascular morbidity and mortality 1.